Ordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 1st December 2022
Solactive China Healthcare Disruption Index:
In the ordinary rebalancing effective open December 01, 2022 the following index composition was implemented:
| 3SBIO INC | 1.3032 % |
| AIM VACCINE CO LTD | 1.7454 % |
| AK MEDICAL HOLDINGS LTD | 0.5557 % |
| AKESO INC | 1.825 % |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 5.5959 % |
| ANGELALIGN TECHNOLOGY INC | 1.0565 % |
| CANSINO BIOLOGICS INC | 2.1093 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 1.7984 % |
| CSPC PHARMACEUTICAL GROUP LTD | 7.7217 % |
| GENSCRIPT BIOTECH CORP | 2.7063 % |
| GRAND PHARMACEUTICAL GROUP LTD | 0.9449 % |
| GUSHENGTANG HOLDINGS LTD | 0.6305 % |
| HANSOH PHARMACEUTICAL GROUP CO | 5.662 % |
| INNOCARE PHARMA LTD | 1.2637 % |
| INNOVENT BIOLOGICS INC | 3.0422 % |
| JD HEALTH INTERNATIONAL INC | 8.2672 % |
| JOINN LABORATORIES CHINA C-H | 2.2831 % |
| KEYMED BIOSCIENCES INC | 0.9159 % |
| LIFETECH SCIENTIFIC CORP | 0.7527 % |
| LIVZON PHARMACEUTICAL GROUP INC | 2.286 % |
| LUYE PHARMA GROUP LTD | 0.699 % |
| MICROPORT SCIENTIFIC CORP | 2.1631 % |
| PING AN HEALTHCARE AND TECHNOL | 1.4102 % |
| REMEGEN CO LTD-H | 2.4011 % |
| SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD | 3.3217 % |
| SHANGHAI BIO-HEART BIOLOGI-H | 0.2967 % |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 6.5379 % |
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD | 0.8276 % |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 3.8286 % |
| SHANGHAI MICROPORT MEDBOT GR | 1.8565 % |
| SIMCERE PHARMACEUTICAL GROUP | 1.7645 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 5.5813 % |
| WUXI APPTEC CO LTD | 7.3941 % |
| WUXI BIOLOGICS CAYMAN INC | 7.727 % |
| ZAI LAB LTD | 1.725 % |